Elizabeth Miller, Pharm.D., Acting Deputy Associate Commissioner for Inspections and Investigations (DACII)
Elizabeth Miller, Pharm.D. is the Acting Deputy Associate Commissioner for Inspections and Investigations (DACII) in the FDA Office of Inspections and Investigations (OII).
Elizabeth is a seasoned professional in regulatory excellence, public health, and medical product safety, and most recently served as Deputy Associate Commissioner for Medical Products, overseeing OII’s Medical Products Inspectorate. Combined with her prior position as the Assistant Commissioner for Medical Products and Tobacco Operations, Elizabeth has managed large volumes of FDA inspections relating to drugs, medical devices, biologics, bioresearch monitoring, and tobacco products. Her extensive background includes executive leadership at U.S. Pharmacopeia (USP), where she helped shape regulatory science collaboration, public policy, and governmental affairs while working alongside federal agencies, industry leaders, and international regulators.
Elizabeth's federal career began at the FDA’s Center for Drug Evaluation and Research, where she led the Office of Unapproved Drugs and Labeling Compliance’s Division of Nonprescription Drugs and Health Fraud. Before her government service, she contributed to USP’s medication safety standards and drug information initiatives and began her career as a clinical pharmacist at MedStar Washington Hospital Center. She holds a Doctor of Pharmacy degree from the University of Maryland and a biology degree from The Johns Hopkins University.